Patrick Pithua

Efficacy of feeding plasma-derived commercial colostrum replacer for the prevention of transmission of Mycobacterium avium subsp paratuberculosis in Holstein calves.

OBJECTIVE To estimate the relative risk of paratuberculosis (Johnes disease [JD]) in calves fed a plasma-derived colostrum-replacement (CR) product versus raw bovine maternal colostrum (MC). STUDY DESIGN Randomized controlled clinical trial. ANIMALS 497 heifer calves born in 12 JD-endemic commercial Holstein dairy farms located in Minnesota and Wisconsin. PROCEDURES Every calf was separated from its dam within 30 to 60 minutes after birth and systematically assigned to be fed raw bovine MC (control group, n = 261 calves) or CR (treatment group, 236 calves). The calves were monitored to adulthood and tested for Mycobacterium avium subsp paratuberculosis (MAP) infection by use of an ELISA to detect serum antibodies against MAP and bacterial culture for MAP in feces at approximately 30, 42, and 54 months of age. Weibull regression models were used to evaluate the effect of feeding CR (vs raw bovine MC) on the risk of developing JD infection. RESULTS Calves fed CR at birth were less likely (hazard ratio = 0.559) to become infected with MAP (as determined by use of an ELISA, bacterial culture, or both diagnostic tests), compared with the likelihood for calves fed MC at birth. CONCLUSIONS AND CLINICAL RELEVANCE This study revealed that feeding CR reduced the risk of developing MAP infection in Holstein calves born in JD-endemic herds, which implied that feeding raw bovine MC may be a source of MAP for calves. Plasma colostrum-replacement products may be an effective management tool for use in dairy herds attempting to reduce the prevalence of JD.

Evaluation of the association between fecal excretion of Mycobacterium avium subsp paratuberculosis and detection in colostrum and on teat skin surfaces of dairy cows

OBJECTIVE To evaluate the association between fecal excretion of Mycobacterium avium subsp paratuberculosis (MAP) by dairy cows in the periparturient period and detection of MAP DNA in colostrum specimens and on teat skin surfaces. DESIGN Cross-sectional study. ANIMALS 112 Holstein cows. PROCEDURES Fecal specimens were collected within 48 to 72 hours prior to parturition, and colostrum and teat swab specimens were collected immediately after parturition. Detection of MAP in fecal specimens was performed via microbial culture, and detection of MAP DNA in colostrum and teat swab specimens was achieved via a PCR assay targeting the genetic element ISMAP02. Logistic regression was used to model the relationship between MAP fecal shedding status and detection of MAP DNA in colostrum or teat swab specimens. Population attributable fractions for the proportion of colostrum and teat swab specimens containing MAP DNA were also calculated. RESULTS The odds of detecting MAP DNA in colostrum or teat swab specimens in cows with MAP-positive (vs negative) fecal specimens were 2.02 and 1.87 respectively. Population attributable fractions estimates suggested that withholding colostrum from MAP-positive cows could reduce the odds of exposing calves to MAP in colostrum by 18.2%. Not permitting natural suckling by calves could reduce the odds of exposing calves to MAP on the teat surfaces of MAP-positive cows by 19.5%. CONCLUSIONS AND CLINICAL RELEVANCE Results underscored the need for strict adherence to practices that limit contact of calves with adult cows from the time of birth and promote hygienic colostrum handling to avoid possible contamination with MAP during colostrum harvest, storage, or feeding.

Is an individual calving pen better than a group calving pen for preventing transmission of Mycobacterium avium subsp paratuberculosis in calves? Results from a field trial

The objective of this study was to quantify the efficacy of using individual calving pens (ICP) from which manure was removed between successive calving compared with group calving pens (GCP) for limiting transmission of Mycobacterium avium subsp paratuberculosis (MAP) in Holstein calves. Every other pregnant cow in three Minnesota MAP endemic herds was assigned to calve in either the ICP or the GCP within 48-72 h prior to expected calving. Heifer calves born in the ICP were assigned to the intervention group (n=238) while heifer calves born in the GCP were considered controls (n=211). Calves were separated from their dams as soon as was possible once the calf was found. The intervention within the ICP relative to the GCP was the removal of fecal material in the ICP immediately after each birth. Upon enrollment in 2005, calves were monitored into adulthood. Of the original animals enrolled, 318 were tested for MAP at least once in 2007, 2009, or 2010 using serum ELISA (ICP, n=165; GCP, n=141) and bacterial culture of feces (ICP, n=173; GCP, n=145) tests. Cox regression analysis was performed to evaluate the time until MAP test positivity. Cows born in the ICP had a hazard ratio of 0.37 (95% CI=0.34-0.4) for testing MAP serum ELISA positive, compared with cows born in GCP. Similarly, cows born in the ICP had a hazard ratio of 0.09 (95% CI=0.06-0.14) for testing MAP fecal culture positive, compared with cows born in GCP. The Cox proportional-hazard assumption was violated in both models such that differences observed in the instantaneous hazards of MAP positive outcomes between groups (ICP vs. GCP) subsequently diminished overtime. These findings indicate that using ICP for calving delays exposure to MAP in calves and provides an effective strategy for reducing peripartum MAP transmission risks in herds attempting to limit the impact of paratuberculosis.

Clinical trial on type of calving pen and the risk of disease in Holstein calves during the first 90 d of life

Abstract The objective of this study was to evaluate the efficacy of single cow calving pens that are cleaned between calvings vs. multiple cow calving pens for the prevention of calf diarrhea (scours), respiratory disease (pneumonia) and morbidity attributable to any cause. Every other pregnant cow or heifer was moved to either the single cow calving pen (treatment) or the multiple cow calving pen (control) within 48–72h prior to actual calving. The calves born in the single cow calving pens were assigned to the treatment group while the calves born in the multiple calving pens were assigned to the control group. Fecal materials, placental remains, and any other conspicuous dirt were removed from the single cow calving pens between each calving prior to the introduction of the next pregnant cow. The calves were then separated from their dams within 2h of birth. Multiple cow calving pens were managed as usual at the producers’ discretion. Upon birth, the calf managers monitored each enrolled calf for signs of diarrhea, pneumonia plus other morbidity up to 90d of age. The effects of single cow calving pens (vs. multiple cow calving pens) that are cleaned between calvings on the risk of neonatal calf diseases were evaluated using multivariable logistic regression models. Risk of diarrhea (OR=0.93, P =0.75), pneumonia (OR=1.23, P =0.64), and morbidity due to any cause (OR=0.93, P =0.74) were not significantly different between calves born in single cow vs. multiple cow calving pens. The current study found that, given the management situation evaluated, calves born in single cow calving pens were no different than calves born in multiple cow calving pens with respect to calf diseases risk. Long-term follow-up of the calves enrolled in the present study is ongoing to determine the efficacy of single cow calving pen use for the possible prevention of transmission of Mycobacterium avium subsp. paratuberculosis in Holstein calves.

Estimated Prevalence of Caprine Paratuberculosis in Boer Goat Herds in Missouri, USA

The objective of this study was to estimate true animal-level and herd-level prevalence of Mycobacterium avium subsp. paratuberculosis (MAP) antibodies in Missouri Boer goat herds. Sera harvested from blood samples collected from goats ≥24 months of age in 25 Missouri Boer goat herds were tested for presence of MAP antibodies using a commercial ELISA kit. Herds were declared positive for MAP if one or more goats in the herd tested positive for MAP antibodies. True animal, within-herd, and between-herd prevalences were calculated using the Rogan-Gladen estimator and were 1.4% (95% CI = 0.1 to 3.6%), 3% (95% CI = 0 to 6%), and 54.7% (95% CI = 28.2 to 86.2%), respectively. Findings in this study confirmed that MAP infection is endemic in Missouri Boer goat herds.

Lack of evidence for fecal shedding of Mycobacterium avium subsp. paratuberculosis in calves born to fecal culture positive dams.

The objective was to detect presence of calves excreting Mycobacterium avium subsp. paratuberculosis (MAP) in their feces as a consequence of being born to MAP fecal culture positive (vs. negative) dams. For each cow that was about to calf, approximately 10g of feces was collected manually by the herdsmen from the rectum using a disposable plastic examination sleeve within 48-72h prior to actual calving. Between 1 and 3d of birth, herd personnel collected approximately 10g of fecal samples followed by monthly visits to the farm at which time 10g of fecal samples were again collected by study investigators from each calf at approximately 30, 60 and 90d of age. Mycobacterium avium subsp. paratuberculosis was recovered from 8% (5/60) of the cows that gave birth to calves. However, MAP was not recovered from any of the fecal samples (0/240) collected from study calves. Findings of the present study suggest lack of evidence for fecal excretion of MAP in calves born to fecal culture positive (vs. negative) dams in a heavily infected herd.

Experimental Validation of a Nested Polymerase Chain Reaction Targeting the Genetic Element ISMAP02 for Detection of Mycobacterium Avium Subspecies Paratuberculosis in Bovine Colostrum

Colostrum samples experimentally inoculated with Mycobacterium avium subsp. paratuberculosis (MAP; strain K-10) at increasing concentrations between 1 × 101 and 1 × 109 cells/ml were tested for recovery of MAP DNA using a nested ISMAP02 target polymerase chain reaction initially developed for detecting MAP DNA in fecal samples. The following detection rates were achieved for sample replicates inoculated with unsonicated MAP pure stock: 100% between 1 × 107 and 1 × 109 cells/ml, 75% between 1 × 103 and 1 × 106 cells/ml, and 50% between 1 × 101 and 1 × 102 cells/ml replicates. Detection rates achieved for the colostrum sample replicates inoculated with sonicated MAP cell suspension were 75% for 1 × 109 cells/ml, 100% between 1 × 107 and 1 × 108 cells/ml, 75% for 1 × 106 cells/ml, 0 for 1 × 104 cells/ml, and 25% between 1 × 101 and 1 × 103 cells/ml. When negative control colostrum samples were tested, 16 of 18 (89%) samples were correctly detected as negative for MAP DNA using the current assay. In conclusion, the MAP DNA detection rates of the present assay improved with increasing concentrations of MAP in the colostrum sample replicates, although MAP DNA was also detected in 2 of 18 (11%) negative control samples, suggesting an undefined technical problem with the assay or, perhaps, sample contamination during preparation. Overall, the present findings suggest a potential role of the proposed polymerase chain reaction assay to detect MAP in colostrum. However, adoption of this test for use in routine screening of field colostrum for MAP awaits findings from an ongoing field validation study.

Effect of a plasma-derived colostrum replacement feeding program on adult performance and longevity in Holstein cows

OBJECTIVE To evaluate longevity, milk production, and breeding performance in adult Holstein cows fed either a plasma-derived commercial colostrum replacer (CR) or raw bovine maternal colostrum (MC) at birth. DESIGN Randomized controlled clinical trial. ANIMALS 497 heifer calves born in 12 commercial dairies located in Minnesota and Wisconsin. PROCEDURES All calves were separated from their dams within 30 to 60 minutes after birth and systematically assigned to be fed either MC (control group [n = 261 calves]) or CR (treatment group [236]). Calves were observed from birth up to adulthood (approx 54 months old), during which time death and culling events plus milk yield and breeding performance data were collected. Time to death, time to culling, time to death or culling combined, time to first calving, and time to conception intervals were evaluated by use of proportional hazards survival analysis models. Number of times inseminated per conception and lifetime milk yield (up to 54 months old) were evaluated by use of general linear models. RESULTS Cows fed CR as calves at the time of birth were no different than cows fed MC as calves with respect to overall risk of death, culling, or death or culling combined (from birth to 54 months of follow-up and from first calving to 54 months old); lifetime milk yield; and breeding performance. CONCLUSIONS AND CLINICAL RELEVANCE No difference was detected in overall risk of death or culling, milk production, or reproductive performance between cows fed CR and those fed MC as calves at birth.

Evaluation of the risk of paratuberculosis in adult cows fed Mycobacterium avium subsp paratuberculosis DNA-positive or -negative colostrum as calves

OBJECTIVE To estimate the risk of subclinical Mycobacterium avium subsp paratuberculosis (MAP) infection in cows that ingested MAP DNA-positive raw colostrum as calves, compared with risk in cows that ingested MAP DNA-negative raw colostrum as calves. ANIMALS 205 calves born in 12 commercial dairy herds. PROCEDURES Each calf was separated from its dam within 30 to 60 minutes after birth and fed raw colostrum. For each calf, samples of the colostrum fed were collected and tested for the presence of MAP DNA by use of a nested PCR assay for the target gene ISMAP02. Calves fed colostrum positive or negative for MAP DNA were classified into exposed (n = 69) and unexposed (136) groups, respectively. Each calf was tested for MAP infection at 30, 42, and 54 months of age by use of a serum ELISA and bacterial culture of feces. Weibull hazard regression models were used to evaluate the association between exposure to MAP DNA-positive colostrum and time to testing positive for MAP infection. RESULTS Hazard of MAP infection was not different between groups (exposed vs unexposed) when serum ELISA, bacterial culture of feces, or both diagnostic tests (parallel interpretation) were positive. CONCLUSIONS AND CLINICAL RELEVANCE Heifer calves fed MAP DNA-positive colostrum were at no greater risk of MAP infection, compared with heifer calves fed MAP DNA-negative colostrum. This result contradicts findings from other studies and should be interpreted with caution.

Effect of Three Colostrum Diets on Passive Transfer of Immunity and Preweaning Health in Calves on a California Dairy following Colostrum Management Training

Following colostrum management training, a randomized field trial was conducted on a California dairy to determine the effect of supplementing pooled colostrum with either colostrum-derived replacer (CDR) or second-milking colostrum (transition milk) on failure of passive transfer (FPT) and preweaning morbidity risks. A total of 166 calves were randomly assigned to 4L first-milking pooled colostrum (treatment 1), 2L first-milking pooled colostrum and 2L of CDR (treatment 2), or 2L first-milking pooled colostrum and 2L second-milking pooled colostrum (treatment 3). Mean 24-hour serum TP and IgG for treatments 2 (TP 5.2 g/dL, IgG 15.9 g/L) and 3 (TP 5.4 g/dL, IgG 18.3 g/L) did not statistically differ but were significantly lower than for treatment 1 (TP 5.9 g/dL, IgG 24.6 g/L). Risk of FPT did not differ for treatments 1, 2, and 3 (0.0%, 9.3%, and 1.9%, resp.). Similarly, the preweaning risk of diarrhea (81.0%, 92.5%, and 87.0%, resp.) or pneumonia (6.9%, 13.2%, and 18.5%, resp.) did not differ between treatments. Feeding 4L first-milking pooled colostrum resulted in adequate passive transfer. When first-milking pooled colostrum quantity is inadequate, CDR or second-milking pooled colostrum can be used to supplement the required colostrum volume and IgG mass without adversely affecting the risks of FPT or preweaning diarrhea and pneumonia.